Factor I11 of anthrax toxin, which increases the lethality of mixtures of factors I and I1 for mice and decreases their capacity to produce oedema in the skin of rabbits, has been purified. The final preparation showed a single peak in the ultracentrifuge and a single band on paper electrophoresis, but it might still contain more than one serological component.
INTRODUCTION
Bacillus anthracis produces a specific lethal and oedema-forming toxin which was first recognized in vivo, and then produced in vitro (Smith, Keppie & Stanley, 1955;  Harris-Smith, Smith & Keppie 1958; Thorne, Molnar & Strange 1960) . At first the toxin appeared to consist only of two components, factor I and factor 11, which acted synergistically (Smith et . During the further purification of factor I (Stanley & Smith 1961) a third component, factor 111, was recognized in the following way. The final preparation of factor I was not toxic when injected alone; as expected a mixture of factor I with purified non-toxic factor I1 evoked oedema in the skin of a rabbit and killed mice. However, the concentration of this mixture which killed mice formed a much larger skin reaction in rabbits than did a comparable dose (based on mouse LD 50 dose) of either crude toxin or a mixture of crude factors I + 11. An investigation of this observation led to the demonstration of a factor 111, present in crude factor I or 11, which (a) increased the lethality of mixtures of factors I and I1 for mice and decreased their capacity to produce oedema in rabbits; (b) was different serologically from factors I or 11; ( c ) was non-toxic when injected alone; ( d ) was lethal for mice when mixed with factor I1 but not with factor I; ( e ) was present in the anthrax toxin produced in vivo. The present paper describes the purification and properties of factor 111.
METHODS
Crude factor 111 from toxin produced in vitro. Crude anthrax toxin produced by the method of Thorne et al. (1960) was separated into crude factor I and crude factor I1 by filtration through sintered glass filters. Factor I11 was present in the crude factor I (absorbed on glass filters and eluted as described by Stanley & Smith 1961, except that the volume of saturated Na,CO, used to elute the filters was increased to 8 ml.) and in the crude factor I1 (the filtrate). The relative amounts of factor I11 in the eluate from the filters and in the filtrate varied with the particular batch of filters used, but the eluate from a filter always contained more than half the factor I11 in a volume (about 8 ml. from one filter) considerably less than that of the filtrate (1 1. from one filter). Therefore factor I11 was purified from the filter eluate (crude factor I).
Detection and estimation of factor I I I . Factor I11 was present in a solution which was non-toxic when injected alone but which formed a mixture lethal for mice when added to an otherwise non-lethal mixture of purified factor I (4,ug.) +purified factor I1 (4Opg.; see Stanley & Smith 1961, table 5). However, it was more convenient (especially with solutions which contained large amounts of factors I and I1 which affected the mouse test) and less expensive of materials, to fractionate factor I11 by its reaction in serological diffusion plates which used the system and antiserum ('spore' H533) described by Sargeant et al. (1960) and Stanley & Smith (1961) . Preliminary fractionations (Stanley & Smith, 1961) had showed that under these conditions the factor I11 activities of solutions were associated with their ability to form a precipitation line which was different from that formed by purified factors I and 11, and which appeared to be single, although there was some evidence (see later) that it might have been multiple. Fractionation of factor I11 was followed by comparing the null-points (the first dilution which did not form the factor I11 line) of different fractions. Finally, the toxicity (in association with factors I and 11) for mice of the final preparation of factor I11 was compared with that of the original crude eluate, to check that the recovery of activity (mouse-toxicity) in the final product was in fact equal to the recovery indicated by the serological titrations (see later).
PuriJied factors I and I I of anthrax toxin were prepared as described by Stanley & Smith (1961) .
Analytical and physico-chemical methods. These were as described by Stanley & Smith (1961) .
Biological tests for lethality in mice and oedema production in rabbits. These were described by Stanley & Smith (1961) .
RESULTS

PuriJication of factor I I I
A preliminary fractionation of factor I11 from crude factor I1 (i.e. culture filtrate) was described by Stanley & Smith (1961) , and this provided a basis for the first part of the purification of factor I11 from crude factor I (eluate from the filters).
Chromatography on diethylaminoethyl cellulose (DEAEC). Crude factor I (containing factor 111; 320 ml., 'protein' 0.06%, null point of factor 111 line 1/64) was diluted with 0.005I phosphate buffer (pH 7.4; 2880 ml.) and applied to a column (4.5 cm., diam., 10 cm. long) of DEAEC (25 g.) which had been equilibrated with 0 -1 I phosphate buffer (pH 7-4); the flow rate was about 20 ml./min. The column was eluted with 0012I phosphate buffer (pH 7.4; 500 ml.), 0.21 phosphate buffer containing O -O l I NaCl (pH 7.4; 2.5 1.) and 0.2I phosphate buffer containing 0.21 NaCl (pH 7.2; 600 ml.) in 8 x 75 ml. fractions. The latter buffer eluted the factor I11 (in the last six fractions, 450 ml.; null point of factor I11 line 1/16 to 1/32; 0.005 % 'protein') which was contaminated with some factor I (about 5 % of the ' protein ' by comparative titration with purified factor I in serological gel-diffusion Factor 111 of anthrax toxin 519 plates). This fraction was concentrated and the contamination with factor I decreased by the following procedure. After dialysis (overnight, 0-2 ") against 0.011 phosphate buffer (pH 7.4), it was applied to a column (2 cm. diam, 10 cm. long), of DEAEC (3 g.) which had been equilibrated with 0.1 I phosphate buffer (pH 7-4); the flow rate was about 8 ml./min. The column was eluted with 0.21 phosphate buffer containing 0.01 I NaCl (pH 7.4 ; 250 ml.) followed by 0.2 I phosphate buffer containing 0.21 NaCl (pH 7.2; 10 fractions of 10 ml.). Fractions 3-7 of the latter buffer contained the factor I11 (50 ml.; 'protein' 0-036 yo, null point of factor I11 line 1/160). Although contamination with factor I had been decreased (less than 2 yo of the 'protein'), examination of the preparation of factor I11 in the ultracentrifuge showed some smaller and larger molecular material in addition to the main component. The material was then fractionated on hydroxylapatite.
Chromatography on hydroxylapatite. The material (50 ml. ; 'protein' 0.036 yo ; null point of factor I11 line 1/160) was dialysed overnight a t 0-2' against 0-1 M-potassium phosphate buffer (pH 7.0) and applied to a column (2 cm. diam., 10 cm. long) of hydroxylapatite (3 g.) which had been equilibrated with 0.1 M-potassium phosphate buffer (pH 7.0). A slight positive pressure was used to produce a flow rate of about 1-2 ml./min. The column was eluted with 0.1 M-potassium phosphate buffer (pH 7.0; 30 ml.) followed by 0.4~-potassium phosphate buffer (pH 7.0; 50 ml.) in 10 x 5 ml. fractions. Factor I11 was removed by the second buffer and concentrated in 3 of the later fractions which were bulked and concentrated as described below. Concentration by precipitation with ammonium sulphate. The preparation of factor I11 (15 ml., 0.1 yo 'protein', null point of factor I11 line 1/320) was mixed with ammonium sulphate (7.5 g.). After standing overnight (0-2') the precipitate was collected by centrifugation (12,000 g; 30 min. ; O"), dissolved in 0 . 0 5~ phosphate buffer (1.0 ml. ; pH 7.4) and dialysed for 48 hr. at 0-2" against frequent changes of 0 . 0 5 ,~ phosphate buffer (pH 7.4). The preparation was stored at -20'. Recovery of factor 111 activity. In the assay by serological precipitation the final solution (1.5 ml., 'protein' 0.85 %, null point of factor I11 line 1/3200) contained 25-30 yo of the factor I11 originally present in the crude eluate (320 ml., 'protein'
null point of factor I11 line 1/64). This recovery of factor I11 activity was also indicated by the following toxicity tests. When added to a mixture of factor I (Plug.) and factor I1 (40pg.) which alone killed only 10/126 mice, the final preparation of factor I11 in doses of 0.0005 ml. and 0.00025 ml. killed 22/28 and 10/20 mice, respectively. Since 1.5 ml. of the final preparation came from 320ml. of crude eluate, (about 25 yo recovery of activity was indicated) about 0.025 and 0.0125 ml.
of crude eluate should have produced similar death rates in mice as the above doses of purified preparation when tested under similar conditions. For this, the content of factor I in the crude eluate (which is crude factor I +crude factor 111) was estimated (by serological precipitation; see Stanley & Smith 1961) and adjusted to 4pg./ dose by addition of purified factor I before adding purified factor I1 (40,ug./dose) and injecting the mixture into mice. Under these conditions, 0-025 and 0.0125ml. of crude eluate killed 21/30 and 18/30 mice, respectively; these are death rates similar to those produced by the corresponding doses of purified preparation.
The final product was used as prepared (i.e. in 0 . 0 5 ,~ phosphate buffer a t pH 7.4) for ultracentrifugal, electrophoretic and serological analyses and for biological tests ; for chemical analysis the solution was thoroughly dialysed and freeze-dried.
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Criteria of purity Ultracentri$ugation. The final preparation showed a single peak in the ultracentrifuge (Fig. 1) .
Paper electrophoresis. The final preparation of factor I11 was concentrated by dialysis against Carbowax. When examined in 0 . 2 ,~ barbitone buffer (pH 8.6) the material (0.5 mg. dry wt.) migrated, as a single band (9 cm.; in the system described by Stanley & Smith 1961) , towards the anode, It was not examined a t an acid pH value since the concentrated solution precipitated a t pH 5.9. Serological precipitation in gels. Against spore antiserum (H. 533) the final preparation of factor I11 (70 pg.) formed a strong and a faint line; the latter was due to factor I. Appropriate comparative titration with purified factor I indicated that contamination with this factor was less than 2%. The strong line appeared to be single (and remained so on dilution) and was different from the lines formed by purified factors I and 11. However, when certain concentrated fractions containing mixtures of antigens from Bacillus anthracis were diffused side by side with the final preparation of factor 111, two of the lines formed by these mixtures joined with the single line from factor 111. Furthermore, when concentrated solutions were allowed to diffuse for long periods (23 days), on plates having a long distance between the diffusion wells, two closely associated lines were sometimes apparent. Hence the factor I11 line might be composite (compare purified factor 11; Sargeant et al. 1960 ). Attempts to separate two possible components by fractionation on DEAEC and on hydroxylapatite, by fractional precipitation with ammonium sulphate and by precipitation at different acid pH values failed; all the fractions obtained from these procedures showed the same single line on serological diffusion plates.
Properties
Chemical analysis. The final preparation of factor I11 had N 15.1 %; 'protein' (as ovalbumin) 90 % ; carbohydrate (as glucose) less than 0.5 % ; P less than 0.05 % ; lipid less than 1 %; sulphated ash, less than 0.2 %. Paper chromatography of a hydrolysate (6 N-HCl, loo", overnight) showed all the usual amino acids and no others. The ultraviolet absorption spectrum was typical of a protein, and showed no evidence for the presence of nucleic acid.
Biological properties. The final preparation of factor I11 was not lethal for mice when injected (60pg. per mouse) alone; when added to a mixture of purified factor I (4pg.) and factor I1 (40,ug.) which alone killed only 10/126 mice, it (8, 4, 2pg.) produced manymouse deaths (49/66,22/28,10/20 respectively). This activity of factor I11 was not decreased by allowing it to stand for 24 hr. at Oo, 18' or 37'. Addition of the final preparation of factor I11 to mixtures of purified factors I and I1 decreased the capacity of the latter mixtures to produce oedema in the skin of rabbits. Skin lesions of size 16 : 60 produced in rabbits by a mixture of factor I (1.6pg.) +factor I1 (16pg.); (compare Table 5 , Stanley & Smith, 1961) were decreased to 7:23, 9:40, 11:50 by addition of 3.2, 1.6, O+?,ug., respectively, of the best preparation of factor 111. In serological diffusion plates 0.2pg. of the best preparation of factor I11 still formed a line against spore antiserum (H535). Against antigen antiserum (H 25), high concentrations of factor I11 formed only a hazy line which easily dispersed in antigen excess, indicating a low content of factor I11 antibody in this antiserum.
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